Mega Genomics Balance Sheet Health
Financial Health criteria checks 5/6
Mega Genomics has a total shareholder equity of CN¥644.8M and total debt of CN¥22.6M, which brings its debt-to-equity ratio to 3.5%. Its total assets and total liabilities are CN¥796.5M and CN¥151.7M respectively. Mega Genomics's EBIT is CN¥23.9M making its interest coverage ratio -4.8. It has cash and short-term investments of CN¥518.3M.
Key information
3.5%
Debt to equity ratio
CN¥22.64m
Debt
| Interest coverage ratio | -4.8x |
| Cash | CN¥518.29m |
| Equity | CN¥644.83m |
| Total liabilities | CN¥151.72m |
| Total assets | CN¥796.54m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 6667's short term assets (CN¥667.8M) exceed its short term liabilities (CN¥114.3M).
Long Term Liabilities: 6667's short term assets (CN¥667.8M) exceed its long term liabilities (CN¥37.4M).
Debt to Equity History and Analysis
Debt Level: 6667 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 6667's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 6667's debt is well covered by operating cash flow (387.6%).
Interest Coverage: 6667 earns more interest than it pays, so coverage of interest payments is not a concern.